Rydapt Capsules 25mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Rydapt Capsules 25mg contain Midostaurin, a targeted anticancer medicine used for certain forms of acute myeloid leukemia (AML) and advanced systemic mastocytosis in patients with appropriate mutations or disease characteristics.
Product Overview
Product Name: Rydapt Capsules 25mg
Generic Name: Midostaurin
Strength: 25mg
Form: Capsules
Pack Size: As per manufacturer packaging
Used For: Certain types of AML and advanced systemic mastocytosis
Prescription Required: Yes
Ingredients & How They Work
Each capsule contains Midostaurin 25mg. Midostaurin inhibits several kinase enzymes involved in abnormal cancer-cell signaling, including FLT3 and KIT pathways.
Key Benefits
- Used in selected FLT3-mutated AML
- Used for advanced systemic mastocytosis
- Helps inhibit abnormal kinase signaling
- Targeted oral treatment option
How to Use
Take exactly as prescribed by an oncology specialist. Capsules should be swallowed whole with water and should not be opened or crushed.
Side Effects & Precautions
Possible Side Effects
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Fever
- Low blood-cell counts
Precautions
- Requires specialist oncology supervision.
- Blood counts and other laboratory tests may be required.
- Inform your doctor about all medicines because drug interactions are possible.
- Seek medical attention for signs of infection or severe breathing problems.
Storage Instructions
Store below 30°C in a cool, dry place away from moisture and direct sunlight.